{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T07:18:26Z","timestamp":1648711106606},"reference-count":42,"publisher":"Cambridge University Press (CUP)","issue":"3","license":[{"start":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T00:00:00Z","timestamp":1442534400000},"content-version":"unspecified","delay-in-days":11005,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can. j. neurol. sci."],"published-print":{"date-parts":[[1985,8]]},"abstract":"<jats:title>ABSTRACT:<\/jats:title><jats:p>Pituitary adenomas may produce local endocrine and neurological effects, as well as systemic metabolic complications due to hormonal hypersecretion. Medical therapy with pharmacological agents has been developed and is based on the neurotransmitter regulation of normal pituitary hormonal secretion. 189 patients with secretory pituitary adenomas underwent medical therapy for the hypersecretory state. 156 of these were prolactin-secreting adenomas, 16 of which were in males. The response of bromocriptine was almost universal with lowering of serum prolactin and reversal of the clinical symptoms, as well as tumor shrinkage of most large adenomas with suprasellar extension. 23 patients with acromegaly were treated with bromocriptine, with 11 noting clinical improvement, and decreased tumor size in two. Five patients with Cushing\u2019s disease were treated with cyproheptadine, with only one showing a biochemical and clinical improvement. Two patients with Nelson\u2019s syndrome each had progressive tumor growth stabilized with cyproheptadine and bromocriptine in one, and sodium valproate in the other. There appears to be a role for medical therapy in the majority of prolactin-secreting pituitary tumors, some growth hormone secreting pituitary tumors, and selected adrenocorticotropin secreting-pituitary tumors.<\/jats:p>","DOI":"10.1017\/s0317167100047090","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T07:37:06Z","timestamp":1469691426000},"page":"243-250","source":"Crossref","is-referenced-by-count":4,"title":["The Medical Treatment of the Hypersecreting Pituitary Gland"],"prefix":"10.1017","volume":"12","author":[{"given":"Bernard","family":"Corenblum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2015,9,18]]},"reference":[{"key":"S0317167100047090_ref155","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)92100-1"},{"key":"S0317167100047090_ref125","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.287.6390.451"},{"key":"S0317167100047090_ref160","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6065.875"},{"key":"S0317167100047090_ref142","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.0690001"},{"key":"S0317167100047090_ref141","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(81)90342-9"},{"key":"S0317167100047090_ref151","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-85-6-731"},{"key":"S0317167100047090_ref152","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-38-5-836"},{"key":"S0317167100047090_ref161","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1982.tb01602.x"},{"key":"S0317167100047090_ref153","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-42-2-291"},{"key":"S0317167100047090_ref146","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1530\/acta.0.1040160","article-title":"Sodium valproate and cyproheptadine may independently induce remission in the same patient with Cushing\u2019s disease","volume":"104","author":"Koppeschaar","year":"1983","journal-title":"Acta Endocrinol"},{"key":"S0317167100047090_ref154","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198308043090505"},{"key":"S0317167100047090_ref157","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-54-4-780"},{"key":"S0317167100047090_ref123","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)90422-6"},{"key":"S0317167100047090_ref122","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.0770137"},{"key":"S0317167100047090_ref124","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1979.tb02103.x"},{"key":"S0317167100047090_ref139","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-43-1-137"},{"key":"S0317167100047090_ref126","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198101153040306"},{"key":"S0317167100047090_ref138","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1977.tb03343.x"},{"key":"S0317167100047090_ref127","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-38-2-200"},{"key":"S0317167100047090_ref128","first-page":"614","article-title":"Possible anti-tumor effect of 2-bromo-ergocryptine in two patients with large prolactin-secreting pituitary tumors","volume":"23","author":"Corenblum","year":"1975","journal-title":"Clin Res"},{"key":"S0317167100047090_ref129","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-42-5-857"},{"key":"S0317167100047090_ref130","first-page":"153","article-title":"Role of dynamic pituitary testing in patients with hyperprolactinemia","volume":"1","author":"Corenblum","year":"1979","journal-title":"Diagn Gynecol Obstet"},{"key":"S0317167100047090_ref131","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)45913-3"},{"key":"S0317167100047090_ref158","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1982.03320360039028"},{"key":"S0317167100047090_ref132","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)47415-7"},{"key":"S0317167100047090_ref162","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.me.34.020183.001435","article-title":"The medical management of hormone-secreting tumors of the pituitary","volume":"34","author":"Nass","year":"1983","journal-title":"Ann Rev Med"},{"key":"S0317167100047090_ref133","first-page":"205","article-title":"Subclinical adenoma of the pituitary gland","volume":"12","author":"Costello","year":"1936","journal-title":"Am J Pathol"},{"key":"S0317167100047090_ref134","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-56-5-985"},{"key":"S0317167100047090_ref136","first-page":"133","article-title":"Influence of previous bromocriptine therapy on surgery for microprolactinoma","volume":"1","author":"Faglia","year":"1973","journal-title":"Lancet"},{"key":"S0317167100047090_ref137","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.286.6372.1177"},{"key":"S0317167100047090_ref140","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110324"},{"key":"S0317167100047090_ref143","doi-asserted-by":"publisher","DOI":"10.1159\/000396723"},{"key":"S0317167100047090_ref144","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.285.6340.465"},{"key":"S0317167100047090_ref145","article-title":"Sodium valproate and heterogeneity of the pituitary dependent Cushing\u2019s syndrome","volume":"1","author":"Koppeschaar","year":"1982","journal-title":"Lancet"},{"key":"S0317167100047090_ref147","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-4-1-22"},{"key":"S0317167100047090_ref149","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-54-2-286"},{"key":"S0317167100047090_ref150","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)92756-8"},{"key":"S0317167100047090_ref156","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-55-6-1178"},{"key":"S0317167100047090_ref159","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/acta.0.1010491","article-title":"Impaired pituitary response to bromocriptine suppression: reversal after bromocriptine plus tomoxifen","volume":"101","author":"Volker","year":"1982","journal-title":"Acta Endocrinol"},{"key":"S0317167100047090_ref163","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-96-3-281"},{"key":"S0317167100047090_ref135","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1981.tb00649.x"},{"key":"S0317167100047090_ref148","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-51-2-307"}],"container-title":["Canadian Journal of Neurological Sciences \/ Journal Canadien des Sciences Neurologiques"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0317167100047090","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T17:59:23Z","timestamp":1558547963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0317167100047090\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,8]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1985,8]]}},"alternative-id":["S0317167100047090"],"URL":"https:\/\/doi.org\/10.1017\/s0317167100047090","relation":{},"ISSN":["0317-1671","2057-0155"],"issn-type":[{"value":"0317-1671","type":"print"},{"value":"2057-0155","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,8]]}}}